Hi everyone!
As you may know, the ASCPT 2026 Annual meeting is around the corner.
Jane Knöchel (Chair of the SIG) will be attending the conference and plans to share a summary of the survey results with the community afterwards.
- Will any of you be attending ASCPT as well? If so, it would be great to take the chance to meet each other in person!
For the session entitled "From Black Box to Better Health: Debating AI's Role in Clinical Pharmacology and Drug Development" -- chaired by Caroline Grant (AbbVie) and Mohamed Shahin (Pfizer) -- a 10min survey has been created to collect perspectives on where AI/ML can add real value in Clinical Pharmacology and Drug Development, and where important risks and limitations remain.
I thought it would be highly relevant to our community, so I wanted to share it here.
The results will be presented on March 5
Curious to hear what you think about some of the survey questions!
------------------------------
Elba Raimundez Alvarez
Sanofi
------------------------------